Transforming The Management Of Critical Bleeding and Clotting
HemoSonics is bringing to market a next-generation point-of-care diagnostic platform, the Quantra Dx™, that provides actionable information to guide the management of critical bleeding and clotting.
Our goal is to improve outcomes and reduce healthcare costs by enabling more targeted selection and dosing of blood products in critical settings. We seek to transform the way clinicians manage coagulation dysfunctions by providing comprehensive, timely and accurate information on coagulation status at the point of care, enabling clinicians to rapidly choose the right treatment, dramatically improving outcomes and lowering treatment costs.
Studies show that use of comprehensive point-of-care coagulation testing in surgical settings leads to:
Improved clinical outcomes
- Fewer transfusions
- Fewer complications
Reduced cost of care
- Reduced blood product utilization
- Shorter inpatient stays